Value of provider education in the clinical adoption of biomarkers

Panelists discuss how provider education is essential for successful adoption of new biomarkers like IsoPSA. They point out that many clinicians remain unfamiliar with test mechanisms, interpretation, or integration into workflows.

Panelists discuss how training initiatives, institutional support, and access to clinical data can help overcome barriers. When providers understand the evidence base and practical applications, confidence in using IsoPSA grows.

Panelists discuss how systemic factors such as reimbursement, staffing, and electronic health record integration also influence adoption. Improved awareness and operational support will be critical for broader clinical use of IsoPSA and related biomarkers.